New Novartis data show Piqray effectiveness across key biomarkers in patients with HR+/HER2-…
Biomarker analysis from phase-III Solar-1 study shows Piqray plus fulvestrant had clinical benefit regardless of presence of ESR1…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.